Hematology News

When using current guideline recommendations, the clinical net benefit of starting oral anticoagulation varied widely among patients with atrial fibrillation, according to findings published in Annals of Internal Medicine.

A $4.7 million grant from the NHLBI will support a Cleveland Clinic-led research consortium’s effort to develop a better risk-prediction tool for cancer-associated venous thromboembolism.

Patients with deep vein thrombosis who underwent immediate compression therapy had significantly lower rates of residual vein obstruction and post-thrombotic syndrome than those who received no compression, according a multicenter prospective study.

Among older adults, low-dose aspirin did not reduce CVD risk vs. placebo and conferred an increase in risk for major hemorrhage, according to results of the ASPREE trial.

SAN DIEGO – Evidence supporting the use of plasma transfusions in a variety of clinical situations, including prolonged pump time during open heart surgery and trauma-related massive hemorrhage, appears to be mixed, according to an analysis presented at the 38th Annual Cardiothoracic Surgery Symposium.

Extended thromboprophylaxis with weight-adjusted tinzaparin appeared safe and effective for patients following bariatric surgery, according to results of a single-center retrospective cohort study.

Outpatient treatment appeared safe for select patients with acute pulmonary embolism with low risk for mortality, according a single-arm, prospective study.

The FDA approved antihemophilic factor (recombinant) PEGylated-aucl for the routine prophylactic treatment of hemophilia A among previously treated adults and adolescents aged 12 years or older.

Emicizumab prophylaxis significantly reduced the bleeding rate among children with hemophilia A without factor VIII inhibitors, according to results of the multicenter, open-label, randomized phase 3 HAVEN 3 study published in The New England Journal of Medicine.

Several leaders in hematology will be honored through awards and special lectures at ASH Annual Meeting and Exposition, scheduled for Dec. 1-4 in San Diego.